Sign In
Buy ENTX
$1.22
-0.0300 (-2.40%)
At Close: Jun 03, 2026
Entera Bio Ltd. (ENTX) Flat As Market Gains: What You Should Know
07:34pm, Thursday, 02'nd Feb 2023
Entera Bio Ltd. (ENTX) closed at $0.95 in the latest trading session, marking no change from the prior day.
Entera Bio Ltd. (ENTX) Flat As Market Sinks: What You Should Know
07:33pm, Wednesday, 25'th Jan 2023
In the latest trading session, Entera Bio Ltd. (ENTX) closed at $0.95, marking no change from the previous day.
New Strong Buy Stocks for December 29th
09:47am, Thursday, 29'th Dec 2022
SPNS, CRS, DHT, DCBO and ENTX have been added to the Zacks Rank #1 (Strong Buy) List on December 29, 2022.
Centillion Fund Inc. Ups Stake in Entera Bio (ENTX)
01:55am, Wednesday, 23'rd Nov 2022
Fintel reports that Centillion Fund Inc.
New Strong Buy Stocks for November 21st
09:47am, Monday, 21'st Nov 2022
AMRK, ACR, EDAP, H and ENTX have been added to the Zacks Rank #1 (Strong Buy) List on November 21, 2022.
New Strong Buy Stocks for November 16th
09:02am, Wednesday, 16'th Nov 2022
ENTX, STIM, FN, ANGN and FUTU have been added to the Zacks Rank #1 (Strong Buy) List on November 16, 2022.
Entera Bio to Present at H.C. Wainwright 24th Annual Global Investment Conference
04:30pm, Monday, 12'th Sep 2022
JERUSALEM, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, tod
Entera Bio Outlines Pivotal Osteoporosis Trial, Names New CEO
09:23am, Monday, 18'th Jul 2022
Following its End of Phase 2 Meeting with the FDA, Entera Bio Ltd (NASDAQ: ENTX) has designed the pivotal study for EB613 as an 18-month double-blind placebo-controlled study, followed by a 6-mont
Entera Bio Ltd. (ENTX) CEO Spiros Jamas on Q1 2022 Results - Earnings Call Transcript
02:34pm, Wednesday, 18'th May 2022
Entera Bio Ltd. (NASDAQ:ENTX ) Q1 2022 Earnings Conference Call May 17, 2022 8:00 AM ET Company Participants Spiros Jamas - Chief Executive Officer Miranda Toledano - Chief Business Officer, Chief Fin
Follow the Insiders and Buy the Dip in These 3 Stocks
03:15pm, Friday, 06'th May 2022
These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments.
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
05:02pm, Friday, 08'th Apr 2022
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now. The post Recession Fears are Creating a Golden Opportunity for Biotech S
Entera Bio''s (ENTX) CEO Spiros Jamas on Q4 2021 Results - Earnings Call Transcript
04:09pm, Tuesday, 08'th Mar 2022 Seeking Alpha
Entera Bio GAAP EPS of -$0.47 beats by $0.58, revenue of $0.57M beats by $0.03M
11:44am, Tuesday, 08'th Mar 2022 Seeking Alpha
Entera Bio press release (ENTX): FY GAAP EPS of -$0.47 beats by $0.58.Revenue of $0.57M (+54.1% Y/Y) beats by $0.03M.
Entera Bio's (ENTX) CEO Spiros Jamas on Q4 2021 Results - Earnings Call Transcript
11:09am, Tuesday, 08'th Mar 2022
Entera Bio's (ENTX) CEO Spiros Jamas on Q4 2021 Results - Earnings Call Transcript
Entera Bio to Report Business and Financial Results for the Year Ended December 31, 2021 on March 8, 2022
09:50am, Thursday, 03'rd Mar 2022
BOSTON and JERUSALEM, March 03, 2022 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced today it will report bus
